Metraipolis › archive › dc_de332ca765a4

Emerging pharmacological targets in migraine therapy: CGRP and beyond — Europe PMC PMID:42781272

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42781272
DOI
10.3389/fphar.2026.1924544
License (as archived)
solo-consultazione
Archived
2026-10-15T18:55:16.241Z
SHA-256 of the archived text
c71a0bcd7f6efcac3c5b18e1073b96963dfd72926658cc57c030dec73a112d62
Stable URL of this page
https://metraipolis.com/documento/dc_de332ca765a4

How to cite

Emerging pharmacological targets in migraine therapy: CGRP and beyond — Europe PMC PMID:42781272 — Europe PMC (en), https://europepmc.org/article/MED/42781272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_de332ca765a4 (Metraipolis archive dc_de332ca765a4, sha256 c71a0bcd7f6efcac3c5b18e1073b96963dfd72926658cc57c030dec73a112d62)
BibTeX
@misc{dcde332ca765a4,
  title = {Emerging pharmacological targets in migraine therapy: CGRP and beyond — Europe PMC PMID:42781272},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42781272},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_de332ca765a4; sha256 c71a0bcd7f6efcac3c5b18e1073b96963dfd72926658cc57c030dec73a112d62},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42781272. Agents can read the archived copy with the MCP tool read_document.